Wolfgang Ahrens Selected Research

asphalt

10/2010	Exposure assessment for a nested case-control study of lung cancer among European asphalt workers.
10/2010	A case-control study of lung cancer nested in a cohort of European asphalt workers.
9/2009	Elevated cancer mortality in a German cohort of bitumen workers: extended follow-up through 2004.
9/2003	Mortality from obstructive lung diseases and exposure to polycyclic aromatic hydrocarbons among asphalt workers.
1/2003	Performance of different exposure assessment approaches in a study of bitumen fume exposure and lung cancer mortality.
1/2003	Cancer mortality among European asphalt workers: an international epidemiological study. I. Results of the analysis based on job titles.
1/2003	Estimating exposures in the asphalt industry for an international epidemiological cohort study of cancer risk.
1/2003	Cancer mortality among European asphalt workers: an international epidemiological study. II. Exposure to bitumen fume and other agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang Ahrens Research Topics

Disease

27	Neoplasms (Cancer) 04/2022 - 01/2003
24	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2002
11	Obesity 01/2022 - 04/2012
9	Overweight 01/2022 - 04/2012
9	Insulin Resistance 01/2022 - 07/2013
6	Laryngeal Neoplasms (Laryngeal Cancer) 01/2020 - 03/2004
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2011
3	Pediatric Obesity 01/2022 - 04/2012
3	Uveal melanoma 10/2020 - 01/2012
3	Male Breast Neoplasms (Male Breast Cancer) 10/2020 - 12/2010
3	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2009
3	Squamous Cell Carcinoma of Head and Neck 01/2017 - 03/2016
3	Oropharyngeal Neoplasms 12/2016 - 12/2009
3	Seminoma 09/2013 - 11/2006
3	Carcinoma (Carcinomatosis) 07/2011 - 03/2004
2	Abdominal Obesity 01/2022 - 10/2019
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Infections 01/2022 - 04/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022 - 11/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 01/2020
2	Hypertension (High Blood Pressure) 11/2021 - 01/2017
2	Dyslipidemias (Dyslipidemia) 10/2021 - 10/2015
2	Papillomavirus Infections 10/2021 - 04/2013
2	Heart Failure 01/2021 - 12/2018
2	Stroke (Strokes) 01/2021 - 05/2020
2	Sarcoma (Soft Tissue Sarcoma) 10/2020 - 02/2006
2	Myocardial Infarction 12/2018 - 01/2017
2	Testicular Neoplasms (Testicular Cancer) 03/2012 - 11/2006
2	Cryptorchidism (Undescended Testes) 03/2012 - 10/2010
1	Prediabetic State (Prediabetes) 01/2022
1	Dementia (Dementias) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2020
1	Chronic Disease (Chronic Diseases) 09/2020
1	Communicable Diseases (Infectious Diseases) 04/2020
1	Asthma (Bronchial Asthma) 04/2020
1	Leukemia 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	AIDS-Related Complex (ARC) 01/2019
1	Infarction (Infarctions) 12/2018
1	Cardiogenic Shock 12/2018
1	Acute Kidney Injury (Acute Renal Failure) 12/2018
1	ST Elevation Myocardial Infarction 12/2018
1	Body Weight (Weight, Body) 09/2018

Drug/Important Bio-Agent (IBA)

12	ORALIT (ORS)IBA 01/2021 - 02/2006
11	CarcinogensIBA 01/2022 - 01/2003
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2012
8	asphaltIBA 10/2010 - 01/2003
6	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022 - 09/2003
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 07/2013
6	LipidsIBA 05/2020 - 01/2017
6	AsbestosIBA 01/2020 - 02/2002
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
4	HDL CholesterolIBA 10/2021 - 07/2013
4	SolventsIBA 01/2018 - 12/2010
3	hydroxide ionIBA 04/2022 - 06/2014
3	Biological ProductsIBA 04/2020 - 09/2012
3	SugarsIBA 09/2018 - 09/2012
3	Petroleum (Crude Oil)IBA 01/2018 - 12/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 04/2013
3	AntibodiesIBA 04/2015 - 11/2008
3	SmokeIBA 02/2014 - 04/2011
3	Coal Tar (Estar)IBA 10/2010 - 01/2003
2	C-Reactive ProteinIBA 01/2022 - 11/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2007
2	VaccinesIBA 10/2021 - 01/2020
2	Insulin (Novolin)FDA Link 07/2021 - 04/2012
2	Glucose (Dextrose)FDA LinkGeneric 07/2021 - 01/2020
2	Trichloroethylene (Trichloroethene)IBA 10/2020 - 01/2018
2	Polychlorinated Biphenyls (PCBs)IBA 10/2020 - 10/2007
2	Phytoestrogens (Phytoestrogen)IBA 01/2020 - 08/2009
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020 - 01/2020
2	NickelIBA 01/2020 - 11/2019
2	chromium hexavalent ionIBA 01/2020 - 11/2019
2	CholesterolIBA 01/2017 - 07/2013
2	Endocrine DisruptorsIBA 09/2012 - 12/2010
2	Hormones (Hormone)IBA 12/2010 - 08/2009
1	Vitamin D FDA LinkGeneric 04/2022
1	Interleukin-15 (Interleukin 15)IBA 01/2022
1	CytokinesIBA 01/2022
1	LeptinIBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	lipoprotein cholesterolIBA 11/2021
1	OilsIBA 10/2020
1	propylene dichlorideIBA 10/2020
1	ProteomeIBA 09/2020
1	Coenzyme A (CoA)IBA 04/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	HomocysteineIBA 01/2020
1	CarbonIBA 01/2020
1	Vehicle Emissions (Emissions, Vehicle)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	ParaffinIBA 01/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2018
1	Contrast MediaIBA 12/2018

Therapy/Procedure

2	Dental Care 03/2016 - 06/2014
1	Drug Therapy (Chemotherapy) 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Percutaneous Coronary Intervention 12/2018